Do phenomenons such as Brexit and the Trump election victory mean trouble for the pharma industry or are you more optimistic? Take the PharmaBoardroom poll on the pharma industry in 2017 and stay tuned for the results!
Related Content
Italy / Life Sciences Industry Snapshot 2021
An overview of Italy’s pharma, biotech and medtech sectors by number of companies, production value, R&D…
Regulatory, Pricing and Reimbursement Overview: Vietnam
An intro to the legal situation for regulatory, pricing and reimbursement in Vietnamese Pharma. Prepared in…
South Africa / Vaccines Made in Africa to Stay in Africa; Aspen Profits Up 21%; Adcock Ingram’s Down 3%
A roundup of the latest news from South African pharma, including Aspen’s impressive annual growth, Adcock…
China / Fosun Sales up 20%; MNC Price Manoeuvres Lead to Growth; Bayer Sees ‘Golden Age’ Ahead
The latest news from Chinese pharma, including Fosun Pharma’s 2021 interim results; how AstraZeneca, Bayer, Eli…
Ireland / Abbott Splashes the Cash on New R&D Investment; Bausch & Lomb Ramps Up Manufacturing Footprint; Looming Pricing Crisis
The latest news from Irish pharma, including a big new R&D investment for Abbott; contact lens giant Bausch…
China / Hong Chow Leaves Roche for Big New Role at Merck
In a big career move on a personal level and a sign of China’s continuing significance to global pharma, Hong…